5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.31▼ | 6.31▼ | 6.32▼ | 6.32▼ | 6.27▼ |
MA10 | 6.36▼ | 6.37▼ | 6.42▼ | 6.48▼ | 6.21▼ |
MA20 | 6.39▼ | 6.50▼ | 6.54▼ | 6.37▼ | 6.39▼ |
MA50 | 6.55▼ | 6.67▼ | 6.63▼ | 6.26▼ | 5.64▲ |
MA100 | 6.67▼ | 6.46▼ | 6.40▼ | 6.40▼ | 5.07▲ |
MA200 | 6.49▼ | 6.50▼ | 6.49▼ | 5.81▲ | 5.97▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.015▼ | -0.032▼ | -0.048▼ | -0.041▼ | -0.068▼ |
RSI | 24.555▼ | 30.548▼ | 32.264▼ | 45.526▼ | 51.005▲ |
STOCH | 22.409 | 15.743▼ | 8.592▼ | 24.418 | 42.677 |
WILL %R | -95.238▼ | -96.667▼ | -97.600▼ | -88.875▼ | -66.676 |
CCI | -200.962▼ | -168.851▼ | -131.409▼ | -152.442▼ | -54.534 |
Tuesday, October 07, 2025 01:14 PM
Since the first quarter of 2020, the Company has been providing a preliminary look at its unaudited top line results soon after the close of the quarter. The Company expects to continue providing this ...
|
Tuesday, October 07, 2025 01:13 PM
ImmuCell Corporation ( NASDAQ: ICCC) announced on Tuesday preliminary, unaudited sales results for the third quarter of 2025.
|
Monday, September 29, 2025 09:06 AM
PORTLAND, Maine, Sept. 29, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
20/10/25 | 6.23 | 6.23 | 6.09 | 6.16 | 10,782 |
17/10/25 | 6.35 | 6.35 | 6.0561 | 6.06 | 8,929 |
16/10/25 | 6.64 | 6.64 | 6.25 | 6.25 | 12,872 |
15/10/25 | 6.47 | 6.85 | 6.19 | 6.63 | 69,469 |
14/10/25 | 6.79 | 6.99 | 6.52 | 6.52 | 6,102 |
13/10/25 | 6.80 | 6.9818 | 6.58 | 6.58 | 27,437 |
10/10/25 | 6.70 | 6.99 | 6.70 | 6.80 | 26,528 |
09/10/25 | 6.67 | 6.99 | 6.50 | 6.72 | 33,388 |
08/10/25 | 6.55 | 6.8275 | 6.50 | 6.59 | 27,486 |
07/10/25 | 6.58 | 6.66 | 6.45 | 6.45 | 9,183 |
|
|
||||
|
|
||||
|
|